111259 ⎘
ssRNA viruses positive-sense; Details; Coronaviridae; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
SARS CORONAVIRUS 2 RECOMBINANT VECTORS EXPRESSING REPORTER GENES, DERIVED FROM GH CLADE SARS CORONAVIRUS 2 OF KOREAN ISOLATE, AND THE PRODUCTION METHOD THEREFOR
#2SELF-REPLICATING RNA VACCINES AND METHODS OF USE
#3THERAPEUTIC INTERFERING PARTICLES FOR CORONA VIRUS
#4SARS-CoV-2 Virus-Like Particles
#5ONE-TO-STOP ATTENUATED SARS-COV-2 VIRUS
#6AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES
#7COMPOSITIONS AND METHODS TO INCREASE CORONAVIRUS IMMUNE RESPONSE
#8FLEXIBLE EXPRESSION VECTOR SYSTEMS AND APPLICATION OF SAME TO VACCINES AND IMMUNOTHERAPEUTICS
#9RAPID GENERATION OF INFECTIOUS CLONES
#10VACCINE COMPOSITION COMPRISING A LEISHMANIA HOST CELL EXPRESSING AT LEAST ONE PROTEIN OF THE FAMILY CORONAVIRIDAE
#11Coronavirus vaccine
#12MICRO-ELECTROPORATION BASED DRUG DELIVERY SYSTEM, METHODS FOR USE AND FABRICATION THEREOF
#13METHODS FOR CONTROL OF AN INFECTIVE DISEASE WITH A VACCINE
#14CORONAVIRUS REPLICONS FOR ANTIVIRAL SCREENING AND TESTING
#15PARTICLES, DNA & RNA
#16Coronavirus vaccine
#17SINGLE-CHAIN CORONAVIRUS VIRAL MEMBRANE PROTEIN COMPLEXES
#18REAGENTS AND METHODS FOR PREVENTING, TREATING OR LIMITING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) CORONAVIRUS INFECTION
#19DUAL PROMOTER-DRIVEN AND DUAL REPORTER-EXPRESSING SARS-COV-2 REPLICONS AND METHODS OF USE
#20RECOMBINANT VIRUSES, SURFACE-ENGINEERED DELIVERY SYSTEMS AND RELATED METHODS
#21Coronavirus Disease 2019(COVID -19) Recombinant Spike Protein Forming Trimer, Method for Mass Producing Recombinant Spike Protein in Plants, and Method for Preparing Vaccine Composition on Basis Thereof
#22RNA FORMULATIONS FOR HIGH VOLUME DISTRIBUTION, AND METHODS OF USING THE SAME FOR TREATING COVID-19
#23METHOD FOR IMPROVING ANTIGEN IMMUNOGENICITY, CORONAVIRUS ANTIGEN, USE THEREOF, RECOMBINANT VECTOR, EXPRESSION KIT, TRANSGENIC CELL LINE, RECOMBINANT BACTERIUM, CORONAVIRUS VACCINE, PREPARATION METHOD OF ANTIGEN AND NUCLEOTIDE SEQUENCE
#24MODIFIED GENE VACCINES AGAINST AVIAN CORONAVIRUSES AND METHODS OF USING THE SAME
#25MERS-CoV VACCINE
#26DECOY TRANSCRIPTS FOR TREATMENT OF ssRNA VIRAL INFECTION
#27mRNA NANOCAPSULE AND USE IN PREPARATION OF ANTIVIRAL DRUGS
#28Induce and enhance immune responses using recombinant replicon systems
#29Induce and enhance immune responses using recombinant replicon systems
#30Nucleic Acid Encoding TGEV and PRRSV Sequences for Improved Expression of PRRSV Sequences
#31INFECTIOUS CLONES
#32Infectious clones
#33Nucleic acids encoding TGEV and PRRSV sequences for improved expression of PRRSV sequences
#34Vectors based on recombinant defective viral genomes and their use in the formulation of vaccines
#35Purified trimeric S protein as vaccine against severe acute respiratory syndrome virus infections
#36Severe acute respiratory syndrome coronavirus
#37Compositions of coronaviruses with a recombination-resistant genome
#38Nucleic acid sequences encoding proteins capable of associating into a virus-like particle
#39Expression vector encoding coronavirus-like particle
#40Coronavirus-like particles comprising functionally deleted genomes